EU Monitor - 17 February 2012

IMCO Committee Publish Pqd Timescale

The European Parliament’s Internal Market and Consumer Protection Committee (IMCO) published a timeline for conducting its review of the European Commission’s proposals for reform of the Professional Qualifications Directive (PQD). Read more...

Commission announce high level conference on EU Health Programmes

the European Commission announced a high level conference on EU Health Programmes with the tagline “results and future perspectives”. Read more...

ECDC start publishing weekly communicable disease threat report

the European Centre for Disease Prevention and Control (ECDC) commenced publication of a weekly communicable disease threat report (CDTR). Read more...

Bulgaria withdraws support for anti counterfeit agreement

the Bulgarian Government’s Economy and Energy Minister Traicho Traikov told reporters that his country would halt the ratification procedure for the Anti Counterfeiting Trade Agreement (ACTA). Read more...

Commission publish pensions white paper

László Andor, EU Commissioner for Employment, Social Affairs and Inclusion, published a White Paper on “adequate, safe and sustainable pensions”. Read more...

EU Monitor- September 2011

Green Paper on Modernising the Professional Qualifications Directive

The European Commission has issued a Public Consultation on the Green Paper concerning the modernization of the professional qualification directive 2005/36/EC. Read more....

EU Monitor- February 2011

Share your views on the future of clinical trials in Europe

The European Commission is seeking views from stakeholders on the rules that should apply to clinical trials in Europe. Read more....

Raising awareness about rare diseases

EAHP wishes to draw attention to Rare Disease Day 2011 which was organised on 28 February this year around the slogan “rare but equal”. Read more...

New EU rules to tackle counterfeit drugs

EU Ministers and MEPs have struck a deal on new EU legislation to tackle the growing problem of counterfeit drugs.Read more...

EU Monitor - January 2011

Contribute your views to an EU consultation on professional mobility

The European Commission has issued a public consultation on professional mobility in Europe and hospital pharmacists are invited to share their views and experiences. Read more...

Council of Europe adopts resolution on pharmacy preparations for special needs patients

The Council of Europe has adopted a resolution on quality and safety assurance requirements for medicinal products prepared in pharmacies for the special needs of patients. Read more...

Good news for the recognition of cross border prescriptions

EU Ministers and MEPs have reached an agreement on cross border healthcare rules which will pave the way for safer cross border prescriptions. Read more..

Pain Management in Children: views on current practices sought from European Hospital Pharmacists

A survey has been developed by the International Pharmaceutical Federation (FIP), in collaboration with ChildKind International, to obtain a 'snapshot' of current pharmacy resources and practices used to treat paediatric patients (18 years of age or younger). Read more...

New EU Guidance on investigational medical devices

The European Commission has issued new guidance on investigational medical devices. Read more...

Event for your diary: “Active Pharmaceutical Ingredients from Biotechnology:from research to industrial and regulatory issues”14-17 June 2011

Technology for the production of Active Pharmaceutical Ingredients (APIs) is improving, with the aims of developing new products and bio-products, of reducing production costs and improving the quality of final products. In this context, biotechnology plays a crucial role. Read more...

EU Monitor - December 2010

EAHP- EU Monitor December 2010

• Commission identifies EU policy priorities for 2011/12
• Commission consults on changes to GMP guidance
• Joint procurement of vaccines and anti-viral medication

European Commission identifies EU policy priorities for 2011/12

The European Commission has published a work plan setting out the EU policies and legislation which are expected to come under review during the 2011/12 period. EAHP welcomes views from our members on the policy areas which should be identified as priorities, so that we can take forward appropriate advocacy campaigns on your behalf. Read more…

Commission consults on changes to GMP guidance

Hospital pharmacies involved in the production of medicines and which are applying the EU guidance on Good Manufacturing Practice (GMP), should note the European Commission’s proposed changes to the detailed guidance on the production of medicinal products. Read more…

The Commission is also consulting on a revised Chapter 7 of the GMP on outsourced activities. Read more…

Joint procurement of vaccines and anti-viral medication

The European Commission has issued a progress report on work being undertaken to prepare for and manage serious cross border health threats. The Commission’s work focuses on developing a voluntary mechanism for joint procurement at EU level of vaccines and anti-viral medication and updating guidance on flu pandemic preparedness and response planning. Read more…

2010 Archives

View 2010 EU Monitors

EU Monitor November 2010

The single market –what’s in it for hospital pharmacists?

The European Commission has launched a public debate on a package of about 50 measures to revamp the Europe’s single market and stimulate economic growth and employment. The new “Single European Act” includes proposals to review EU rules in areas such as public procurement and mutual recognition of professional qualifications (MRPQ) which have direct implications for pharmacists. Read more...

A new opportunity for the recognition of specialisation in hospital pharmacy?

The European Commission has published more than 170 reports from national authorities offering insight into how EU rules on the mutual recognition of professional qualifications (MRPQ) work in practice in EU members states. The MRPQ rules make it easier for pharmacists to seek employment opportunities in other EU countries by establishing EU wide minimum training requirements which give automatic recognition of their professional qualifications. Read more...

EU Citizens Report 2010 emphasizes need for better e-health access

The “EU Citizens Report 2010” recently published by the European Commission identifies 25 obstacles which EU citizens face in exercising their rights across borders and suggests measures to tackle them.

With regard to health, the Commission highlights that European citizens are not fully benefitting from cross border healthcare and e-health technology.Read more...

A step closer to an agreement on cross border healthcare

Members of the European Parliament’s Public Health Committee have voted on proposals to strengthen patients’ rights to cross border healthcare and have maintained views which are likely to prove controversial with national Governments.

The European Commission’s proposal on cross border health care aims to give patients more legal certainty about their rights to seek healthcare in another EU country and to reinforce cooperation between EU countries. Read more...

The Belgian Presidency reports on EU health priorities

Belgium currently holds the Presidency of the European Union and recently updated health stakeholders on the progress being made at ministerial level on EU health priorities. The presentation was part of a meeting of the EU Health Policy Forum which is organised by the Commission to brief public health stakeholders on the latest news and policy developments. Read more...

European Parliament committee rejects provision of medicines information in printed media

EMA to release access to key documents, says European Ombudsman

Cross-border healthcare legislation in its final phase

Management of chronic pain across the European Union is costing the region billions of Euros

DG SANCO 2010 Management plan

The Council tackles the health workforce dossier

WHO and the European Commission strengthen cooperation

EMA summonsed by European Ombudsman to provide documents on anti-obesity medicines